A new investment firm, LIFE BioCEEd, has raised half a billion Czech crowns to convert medical and biotech discoveries from Central and Eastern Europe (CEE) into market-ready solutions. Co-founder Michal Zahradníček explains how the company’s expertise in science, patient needs, and commercialization helps unlock CEE’s innovation potential, aiming to deliver both strong returns and breakthroughs in healthcare quality.
LIFE bioCEEd hosts its first shareholder meeting at Betlémský Palác marking its official launch.
Stefan Savic, CEO of LIFE bioCEEd, shares the company’s journey in the January issue of Forbes Česko.
LIFE BioCEEd secures 500M CZK to advance medical and biotech innovations, leveraging unique “market entry” expertise.
LIFE bioCEEd is proud to announce the signing of a strategic Memorandum of Understanding (MoU) with Charles University Innovations Prague (CUIP). This collaboration marks a significant step in fostering innovation, bridging research and commercialization, and driving impactful advancements in biotech and medtech.
